Ep190: Neil Kumar on Building a Rare Disease Drug Company

Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

Ep188: Art Krieg on Innate Immune System Activators for Cancer

Ep187: Eric Fischer on Creating a New Class of Medicines

Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope

Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale

Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies

Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors

Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer

Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA

Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

Ep177: Kevin Parker on Finding Cancer Drug Targets

Ep176: David Roblin on Building a TechBio Company

Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

Ep174: Najat Khan on the TechBio Movement

Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders

Ep172: Mostafa Ronaghi on Studying Live Cells at Scale

Ep171: Ram Aiyar on RNA Editing Medicines